MORN3
gene geneOn this page
Summary
MORN3 (MORN repeat containing 3, HGNC:29807) is a protein-coding gene on chromosome 12q24.31, encoding MORN repeat-containing protein 3 (Q6PF18). Assembles a suppression complex (suppresome) by tethering SIRT1 and MDM2 to regulate composite modifications of p53/TP53.
Enables protein-macromolecule adaptor activity. Involved in negative regulation of signal transduction by p53 class mediator. Located in nucleus.
Source: NCBI Gene 283385 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_173855
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29807 |
| Approved symbol | MORN3 |
| Name | MORN repeat containing 3 |
| Location | 12q24.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000139714 |
| Ensembl biotype | protein_coding |
| Entrez | 283385 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 2 nonsense_mediated_decay
ENST00000355329, ENST00000392462, ENST00000542364, ENST00000879182, ENST00000879183, ENST00000879184, ENST00000931069, ENST00000944504
RefSeq mRNA: 2 — MANE Select: NM_173855
NM_001363685, NM_173855
CCDS: CCDS31917
Canonical transcript exons
ENST00000355329 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000939814 | 121654274 | 121654433 |
| ENSE00001036442 | 121659191 | 121659348 |
| ENSE00001411960 | 121669339 | 121669654 |
| ENSE00001412791 | 121653075 | 121653259 |
| ENSE00002294122 | 121648742 | 121651644 |
| ENSE00003534006 | 121652728 | 121652808 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 97.59.
FANTOM5 (CAGE): breadth broad, TPM avg 2.1514 / max 91.1192, expressed in 579 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 133750 | 1.2202 | 476 |
| 133749 | 0.6705 | 117 |
| 133748 | 0.1113 | 21 |
| 133747 | 0.0865 | 26 |
| 133746 | 0.0407 | 20 |
| 133745 | 0.0222 | 9 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.59 | gold quality |
| left testis | UBERON:0004533 | 93.49 | gold quality |
| right testis | UBERON:0004534 | 93.05 | gold quality |
| testis | UBERON:0000473 | 89.70 | gold quality |
| bronchial epithelial cell | CL:0002328 | 89.38 | gold quality |
| bronchus | UBERON:0002185 | 88.12 | gold quality |
| right uterine tube | UBERON:0001302 | 84.13 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 82.10 | gold quality |
| adult organism | UBERON:0007023 | 81.75 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 79.60 | gold quality |
| buccal mucosa cell | CL:0002336 | 79.47 | gold quality |
| upper arm skin | UBERON:0004263 | 78.81 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 77.15 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 76.04 | silver quality |
| cortical plate | UBERON:0005343 | 75.48 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.20 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 74.64 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 74.05 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 73.88 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.83 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 73.63 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 73.48 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.71 | gold quality |
| granulocyte | CL:0000094 | 71.69 | gold quality |
| myocardium | UBERON:0002349 | 71.47 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 71.02 | gold quality |
| placenta | UBERON:0001987 | 70.55 | gold quality |
| ventricular zone | UBERON:0003053 | 70.37 | gold quality |
| quadriceps femoris | UBERON:0001377 | 69.86 | gold quality |
| vastus lateralis | UBERON:0001379 | 69.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
11 targeting MORN3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-1255A | 99.74 | 68.09 | 744 |
| HSA-MIR-1255B-5P | 99.74 | 68.16 | 741 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-4297 | 98.77 | 66.95 | 2013 |
| HSA-MIR-31-5P | 98.58 | 68.35 | 1239 |
| HSA-MIR-1255B-2-3P | 97.80 | 67.04 | 880 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | morn3 | ENSDARG00000021697 |
| mus_musculus | Morn3 | ENSMUSG00000029477 |
| rattus_norvegicus | Morn3 | ENSRNOG00000045574 |
| drosophila_melanogaster | CG30429 | FBGN0050429 |
Paralogs (7): MORN1 (ENSG00000116151), SETD7 (ENSG00000145391), RSPH10B (ENSG00000155026), RSPH1 (ENSG00000160188), RSPH10B2 (ENSG00000169402), ALS2CL (ENSG00000178038), MORN2 (ENSG00000188010)
Protein
Protein identifiers
MORN repeat-containing protein 3 — Q6PF18 (reviewed: Q6PF18)
All UniProt accessions (1): Q6PF18
UniProt curated annotations — full annotation on UniProt →
Function. Assembles a suppression complex (suppresome) by tethering SIRT1 and MDM2 to regulate composite modifications of p53/TP53. Confers both deacetylation-mediated functional inactivation, by SIRT1, and ubiquitination-dependent degradation, by MDM2, of p53/TP53, promoting a proliferative and cell survival behaviors. May play a role in the regulation of spermatogenesis.
Subunit / interactions. Interacts with MEIG1. Interacts with TP53, MDM2 and SIRT1; the interactions mediate post-transcriptional modifications of TP53 by MDM2 and SIRT1.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6PF18-1 | 1 | yes |
| Q6PF18-2 | 2 |
RefSeq proteins (2): NP_001350614, NP_776254* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003409 | MORN | Repeat |
| IPR052472 | MORN3 | Family |
Pfam: PF02493
UniProt features (14 total): repeat 7, region of interest 3, splice variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6PF18-F1 | 92.56 | 0.79 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 46 (showing top):
GOCC_SECRETORY_GRANULE, GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR, GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR, GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR, GOCC_SECRETORY_VESICLE, GOCC_ACROSOMAL_VESICLE, chr12q24, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MARTENS_BOUND_BY_PML_RARA_FUSION, SRC_UP.V1_UP, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP, MIR1255A_MIR1255B_5P, GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP
GO Biological Process (2): negative regulation of signal transduction by p53 class mediator (GO:1901797), signal transduction by p53 class mediator (GO:0072331)
GO Molecular Function (2): protein-macromolecule adaptor activity (GO:0030674), protein binding (GO:0005515)
GO Cellular Component (3): acrosomal vesicle (GO:0001669), nucleus (GO:0005634), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction by p53 class mediator | 1 |
| regulation of signal transduction by p53 class mediator | 1 |
| negative regulation of intracellular signal transduction | 1 |
| intracellular signal transduction | 1 |
| protein binding | 1 |
| molecular adaptor activity | 1 |
| binding | 1 |
| secretory granule | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
752 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MORN3 | MORN5 | Q5VZ52 | 709 |
| MORN3 | PACRG | Q96M98 | 575 |
| MORN3 | RIMBP3 | Q9UFD9 | 575 |
| MORN3 | HOOK1 | Q9UJC3 | 538 |
| MORN3 | KIF3B | O15066 | 493 |
| MORN3 | LRGUK | Q96M69 | 488 |
| MORN3 | SCP2 | P22307 | 468 |
| MORN3 | EEF1E1 | O43324 | 456 |
| MORN3 | CCNI2 | Q6ZMN8 | 456 |
| MORN3 | TCFL5 | Q9UL49 | 450 |
| MORN3 | LNPEP | Q9UIQ6 | 449 |
| MORN3 | CCDC148 | Q8NFR7 | 449 |
| MORN3 | RSPH3 | Q86UC2 | 446 |
| MORN3 | NOC2L | Q9Y3T9 | 442 |
| MORN3 | TMEM120B | A0PK00 | 433 |
IntAct
240 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GOLGA2 | MORN3 | psi-mi:“MI:0915”(physical association) | 0.790 |
| TRAF1 | MORN3 | psi-mi:“MI:0915”(physical association) | 0.790 |
| MORN3 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.790 |
| MORN3 | TRAF1 | psi-mi:“MI:0915”(physical association) | 0.790 |
| MORN3 | RSPH1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| IKZF3 | MORN3 | psi-mi:“MI:0915”(physical association) | 0.780 |
| RSPH1 | MORN3 | psi-mi:“MI:0915”(physical association) | 0.780 |
| MORN3 | IKZF3 | psi-mi:“MI:0915”(physical association) | 0.780 |
| MORN3 | MAGEA6 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRAF2 | MORN3 | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (79): MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid), MORN3 (Two-hybrid)
ESM2 similar proteins: B6CZ17, B6CZ18, O00423, P10830, P53671, Q05BC3, Q08CH7, Q09537, Q15326, Q1XHL7, Q21029, Q28FE4, Q32KM6, Q32KU3, Q32LL6, Q49HM9, Q4R3N2, Q4R842, Q4V8C3, Q4VBJ9, Q502X0, Q569C2, Q5PPV3, Q5TYQ3, Q5VZ52, Q5ZIJ9, Q622Z7, Q63651, Q641X6, Q6GNY1, Q6IND7, Q6PF18, Q6VTH5, Q7DMA9, Q7Z0G7, Q804S5, Q80SY4, Q86YT6, Q8C5T4, Q8K4M9
Diamond homologs: Q32KM6, Q4R842, Q5PPV3, Q6PF18, Q8C5T4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 3 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
670 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:121652744:T:TA | donor_gain | 1.0000 |
| 12:121654267:CACT:C | donor_loss | 1.0000 |
| 12:121654270:TCA:T | donor_loss | 1.0000 |
| 12:121654271:CAC:C | donor_loss | 1.0000 |
| 12:121654272:A:AC | donor_gain | 1.0000 |
| 12:121654272:A:T | donor_loss | 1.0000 |
| 12:121654273:C:A | donor_loss | 1.0000 |
| 12:121654273:C:CA | donor_gain | 1.0000 |
| 12:121654273:CT:C | donor_gain | 1.0000 |
| 12:121669335:TCAC:T | donor_loss | 1.0000 |
| 12:121669336:CAC:C | donor_loss | 1.0000 |
| 12:121669337:A:AC | donor_gain | 1.0000 |
| 12:121669337:A:AG | donor_loss | 1.0000 |
| 12:121669338:C:A | donor_loss | 1.0000 |
| 12:121669338:C:CC | donor_gain | 1.0000 |
| 12:121669338:CCGT:C | donor_gain | 1.0000 |
| 12:121652754:T:TA | donor_gain | 0.9900 |
| 12:121652808:CCTG:C | acceptor_loss | 0.9900 |
| 12:121653102:AGGGG:A | donor_gain | 0.9900 |
| 12:121654265:GGCAC:G | donor_loss | 0.9900 |
| 12:121654266:GCACT:G | donor_loss | 0.9900 |
| 12:121654268:ACTCA:A | donor_loss | 0.9900 |
| 12:121654272:ACT:A | donor_gain | 0.9900 |
| 12:121654273:CTC:C | donor_gain | 0.9900 |
| 12:121654273:CTCA:C | donor_gain | 0.9900 |
| 12:121654273:CTCAG:C | donor_gain | 0.9900 |
| 12:121654292:C:CA | donor_gain | 0.9900 |
| 12:121654293:C:A | donor_gain | 0.9900 |
| 12:121654429:TAACC:T | acceptor_gain | 0.9900 |
| 12:121654432:CC:C | acceptor_gain | 0.9900 |
AlphaMissense
1597 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:121654316:A:G | W141R | 0.978 |
| 12:121654316:A:T | W141R | 0.978 |
| 12:121654354:C:G | R128P | 0.978 |
| 12:121653247:C:G | R159P | 0.970 |
| 12:121659211:A:G | W95R | 0.961 |
| 12:121659211:A:T | W95R | 0.961 |
| 12:121653161:A:G | W188R | 0.960 |
| 12:121653161:A:T | W188R | 0.960 |
| 12:121669360:A:G | W42R | 0.954 |
| 12:121669360:A:T | W42R | 0.954 |
| 12:121654321:C:T | G139E | 0.945 |
| 12:121654357:C:T | G127D | 0.942 |
| 12:121659270:C:T | G75D | 0.942 |
| 12:121654314:C:A | W141C | 0.941 |
| 12:121654314:C:G | W141C | 0.941 |
| 12:121654427:C:A | G104W | 0.940 |
| 12:121659209:C:A | W95C | 0.940 |
| 12:121659209:C:G | W95C | 0.940 |
| 12:121659304:C:A | G64W | 0.940 |
| 12:121653233:A:G | W164R | 0.939 |
| 12:121653233:A:T | W164R | 0.939 |
| 12:121654391:C:G | G116R | 0.939 |
| 12:121659298:A:G | W66R | 0.939 |
| 12:121659298:A:T | W66R | 0.939 |
| 12:121654322:C:G | G139R | 0.938 |
| 12:121654322:C:T | G139R | 0.938 |
| 12:121653239:C:G | G162R | 0.935 |
| 12:121653175:A:G | L183P | 0.933 |
| 12:121654315:C:G | W141S | 0.932 |
| 12:121654426:C:T | G104E | 0.932 |
dbSNP variants (sampled 300 via entrez): RS1000121670 (12:121652093 G>A), RS1000124103 (12:121670041 T>C), RS1000136023 (12:121662580 C>A,G,T), RS1000178381 (12:121665747 A>C), RS1000230726 (12:121665393 C>G), RS1000246464 (12:121668689 G>A), RS1000250885 (12:121668402 G>A,C), RS1000359393 (12:121659482 C>T), RS1000440800 (12:121674148 G>A), RS1000519226 (12:121667252 G>A), RS1000581056 (12:121660840 G>C,T), RS1000904295 (12:121651418 C>T), RS1000970157 (12:121658358 G>A,C), RS1001129430 (12:121661395 A>G), RS1001247467 (12:121667762 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Estradiol | affects cotreatment, decreases expression | 2 |
| Valproic Acid | affects cotreatment, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| sotorasib | affects cotreatment, decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | increases expression, affects cotreatment | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Arsenic | affects methylation | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Genistein | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.